Symptomatic treatment for patients w/ benign prostatic hyperplasia (BPH) & alternative to surgical correction of the hyperplasia, particularly in patients who are not candidates for or willing to undergo surgery.
ESRD (CrCl <10 mL/min/1.73 m2) Examine patients for prostate carcinoma or other conditions which can cause the same manifestations as BPH prior to initial therapy. Perform digital rectal exam & PSA determination before treatment & at regular intervals thereafter. Risk of intraoperative floppy iris syndrome (IFIS), priapism, CV adverse effects; patients w/ serious or life-threatening reactions.
Sign Out
